BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11313874)

  • 1. Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance.
    Turton NJ; Judah DJ; Riley J; Davies R; Lipson D; Styles JA; Smith AG; Gant TW
    Oncogene; 2001 Mar; 20(11):1300-6. PubMed ID: 11313874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance in chemotherapy for breast cancer.
    Saeki T; Tsuruo T; Sato W; Nishikawsa K
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
    Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
    Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1p31, 7q21 and 18q21 chromosomal aberrations and candidate genes in acquired vinblastine resistance of human cervical carcinoma KB cells.
    Wang J; Tai LS; Tzang CH; Fong WF; Guan XY; Yang M
    Oncol Rep; 2008 May; 19(5):1155-64. PubMed ID: 18425371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells.
    Zampieri L; Bianchi P; Ruff P; Arbuthnot P
    Anticancer Res; 2002; 22(4):2253-9. PubMed ID: 12174911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.
    Buys TP; Chari R; Lee EH; Zhang M; MacAulay C; Lam S; Lam WL; Ling V
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1069-79. PubMed ID: 17726699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells.
    Mallory JC; Crudden G; Oliva A; Saunders C; Stromberg A; Craven RJ
    Mol Pharmacol; 2005 Dec; 68(6):1747-56. PubMed ID: 16150928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines.
    Wang J; Chan JY; Fong CC; Tzang CH; Fung KP; Yang M
    Liver Int; 2009 Oct; 29(9):1338-47. PubMed ID: 19627484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells.
    Kurebayashi J; Nukatsuka M; Nagase H; Nomura T; Hirono M; Yamamoto Y; Sugimoto Y; Oka T; Sonoo H
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):515-25. PubMed ID: 16900372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
    Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
    Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?
    Azab SS; Salama SA; Abdel-Naim AB; Khalifa AE; El-Demerdash E; Al-Hendy A
    Breast Cancer Res Treat; 2009 Jan; 113(1):9-19. PubMed ID: 18228136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y; Qian F; Wei D; Liu J
    J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
    Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
    Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A
    J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
    Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
    Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling in chemoresistant variants of three cell lines of different origin.
    Johnsson A; Vallon-Christensson J; Strand C; Litman T; Eriksen J
    Anticancer Res; 2005; 25(4):2661-8. PubMed ID: 16080509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.